Acorda says MS drug, Ampyra benefits lasted up to 5 years

Dalfampridine, or Ampyra, is a potassium channel blocker that is shown to improve visual function, motor skills and relieve fatigue in MS patients.

Acorda says MS drug, Ampyra benefits lasted up to 5 years

Postby MSUK » Thu Apr 26, 2012 2:14 am

Image

Acorda Therapeutics Inc. said Wednesday that clinical study data shows its multiple sclerosis drug Ampyra continued to help patients for up to five years.

Ampyra is used to improve the walking speed in MS patients. The company said Wednesday that the benefits of Ampyra that were observed in clinical trials continued for as much as five years in extension studies. The report was based in 483 patients who participated in a late-stage clinical trial of the drug and agreed to join the extension study.

Acorda said patient's walking speed was measured three times in the first six months of the extension study and once every six months after that. The company presented data from the study at the American Academy of Neurology Meeting in New Orleans....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1310
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 1982
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Ampyra

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users